pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,445 catalysts · 5,159 phase readout · 2,286 8k filing · 315 pdufa · 256 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 14 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: 8k filing×type: phase readout×clear all
type
  • phase readout5,159
  • 8k filing2,286
  • pdufa315
  • earnings256
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›RECRUITINGphase readoutNCT07613710: A Trial to Test the Safety and Tolerability of Lu AH69593 in Adults That Are Healthy or Have Narcolepsy

Sponsor: H. Lundbeck A/S. Phase: PHASE1. Conditions: Narcolepsy

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07552610: Sivelestat Sodium as an Adjunct to Endovascular Thrombectomy for Acute Anterior Circulation Large-Vessel Occlusion

Sponsor: Xuanwu Hospital, Beijing. Phase: NA. Conditions: Acute Ischemic Stroke, Large Vessel Occlusion, Thrombectomy, Neutrophil Extracellular Trap Formation

full page →ctgov ↗
›RECRUITINGphase readoutNCT06101810: The Efficacy of Treatments to Improve Self-esteem

Sponsor: GGZ Noord-Holland-Noord. Phase: NA. Conditions: Self Esteem

full page →ctgov ↗
›RECRUITINGphase readoutNCT06728410: A Phase II Study of Pemigatinib Plus Durvalumab in Previously Treated Advanced Intrahepatic Cholangiocarcinoma Patients With FGFR-2 Fusion or Rearrangement

Sponsor: Mehmet Akce. Phase: PHASE2. Conditions: Intrahepatic Cholangiocarcinoma, FGFR2 Gene Rearrangement, FGFR2 Gene Mutation

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07053813: Applying Population Management Best Practices to Preventative Genomic Medicine Trial

Sponsor: University of Washington. Phase: NA. Conditions: Neoplastic Syndromes, Hereditary

full page →ctgov ↗
›COMPLETEDphase readoutNCT07191613: Effects of HAPPY GO GO Game on Health of Rural Elderly

Sponsor: Chang Gung University of Science and Technology. Phase: NA. Conditions: Frailty at Older Adults, Health Promotion

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07392060: A Phase III Clinical Study of WX390 Combined With Toripalimab Versus Investigator's Choice of Therapy in Patients With Recurrent or Metastatic Cervical Cancer Who Have Failed Prior Platinum-Based Treatment

Sponsor: Shanghai Jiatan Pharmatech Co., Ltd. Phase: PHASE3. Conditions: Cervical Cancer Metastatic

full page →ctgov ↗
›COMPLETEDphase readoutNCT02860260: Kinetics of Plasma and Serum Levels of Brain-Derived Neurotrophic Factor (BDNF) in Patients With Ischemic Stroke

Sponsor: Centre Hospitalier Universitaire Dijon. Phase: NA. Conditions: Ischemic Stroke

full page →ctgov ↗
›COMPLETEDphase readoutNCT07410260: Extracorporeal Shock Wave Therapy for Shoulder Impingement

Sponsor: Istinye University. Phase: NA. Conditions: Extracorporeal Shock Wave Therapy, Shoulder Impingement Syndrome

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07381660: SBRT Versus Surgical Resection for Small HCC

Sponsor: Sun Yat-sen University. Phase: PHASE3. Conditions: Hepatocellular Carcinoma (HCC)

full page →ctgov ↗
›COMPLETEDphase readoutNCT05156320: Efficacy and Safety of Apitegromab in Patients With Later-Onset Spinal Muscular Atrophy Treated With Nusinersen or Risdiplam

Sponsor: Scholar Rock, Inc.. Phase: PHASE3. Conditions: Spinal Muscular Atrophy, Spinal Muscular Atrophy Type 3, Spinal Muscular Atrophy Type 2, SMA, Neuromuscular Diseases, Muscular Atrophy, Atrophy, Muscular Atrophy, Spinal, Neuromuscular Manifestations, Anti-myostatin

full page →ctgov ↗
›RECRUITINGphase readoutNCT07176624: The PRE-VAIL Study

Sponsor: The First Hospital of Jilin University. Phase: NA. Conditions: ARDS (Moderate or Severe), Prone Position, Enteral Nutrition Feeding, Intensive Care Unit (ICU) Admission

full page →ctgov ↗
›COMPLETEDphase readoutNCT05223959: Culturally Adapted Psychoeducation for Bipolar Disorder in a Low-resource Setting: A Randomized Controlled Trial

Sponsor: Pakistan Institute of Living and Learning. Phase: NA. Conditions: Bipolar Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT07578480: MEN-ENDO: Menstrual Stem Cells in Endometriosis

Sponsor: Francisco Algaba Chueca. Phase: . Conditions: Endometriosis

full page →ctgov ↗
›COMPLETEDphase readoutNCT04276480: Efficacy of Piperacillin-tazobactam as Empirical Antimicrobial Therapy for VAP Among ESBL-E Carriers.

Sponsor: University Hospital, Bordeaux. Phase: NA. Conditions: Enterobacteriaceae Infections

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07419880: Re-challenge Immunotherapy With Cromolyn, TQB2102, and Panpulimab in Immune-Refractory Triple Negative Breast Cancer

Sponsor: Fudan University. Phase: PHASE2. Conditions: Triple -Negative Breast Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07643480: Effectiveness of a Digital Prehabilitation Programme Before ACL Reconstruction

Sponsor: Alejandro Caña Pino. Phase: NA. Conditions: Anterior Cruciate Ligament Injury

full page →ctgov ↗
›RECRUITINGphase readoutNCT07427680: Study of TGM-312-SC01 in Healthy Participants and Adults With MASH

Sponsor: Tangram Therapeutics Plc. Phase: PHASE1. Conditions: Healthy Participants, MASH - Metabolic Dysfunction-Associated Steatohepatitis

full page →ctgov ↗
›COMPLETEDphase readoutNCT04960280: A Study to Evaluate a Computerized Stethoscope Called ©Voqx to Diagnose Heart Disease

Sponsor: Mayo Clinic. Phase: NA. Conditions: Isolated Aortic Stenosis, Mitral Regurgitation

full page →ctgov ↗
›COMPLETEDphase readoutNCT07477379: Effects of a Six-Week Change-of-Direction Repeated Sprint Training Program on Explosive Power and Agility in Youth Basketball Players

Sponsor: Inonu University. Phase: NA. Conditions: Explosive Power, Sprint Performance, Agility

full page →ctgov ↗
›RECRUITINGphase readoutNCT07470879: A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis

Sponsor: Pfizer. Phase: PHASE2. Conditions: Colitis, Ulcerative

full page →ctgov ↗
›RECRUITINGphase readoutNCT07589296: Robot-Assisted Gait Training vs NMES in Parkinson's Disease

Sponsor: Kanuni Sultan Suleyman Training and Research Hospital. Phase: NA. Conditions: Parkinson Disease (PD)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07560462: Budesonide Following Endoscopic Dilatation of Esophageal Strictures in Children.

Sponsor: Shaare Zedek Medical Center. Phase: NA. Conditions: Esophageal Stricture

full page →ctgov ↗
›COMPLETEDphase readoutNCT07355946: The Effect of Nurse-Led Coaching Program on Self-Care Agency and Quality of Life in Reconstructed Breast Cancer Patients

Sponsor: Gazi University. Phase: NA. Conditions: Breast Reconstruction

full page →ctgov ↗
›RECRUITINGphase readoutNCT07608588: Recovery From Post-Stroke Aphasia With rTMS Targeting Left or Right Anterior Temporal Lobe

Sponsor: University of South Carolina. Phase: NA. Conditions: Stroke, Aphasia

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07458503: tDCS Combined With Constraint-Induced Therapy in Post-Stroke Upper Limb Rehabilitation

Sponsor: Universidade do Estado do Pará. Phase: NA. Conditions: Stroke, Upper Limb Motor Impairment, Post-Stroke Hemiparesis

full page →ctgov ↗
›RECRUITINGphase readoutNCT07266103: Mechanistic Study of Personalized rTMS in Chronic Pain

Sponsor: Aalborg University. Phase: NA. Conditions: Chronic Pain

full page →ctgov ↗
›RECRUITINGphase readoutNCT07535203: Fontan Outcomes in Oligemia vs Plethora in Univentricular CHD

Sponsor: Sisca Natalia Siagian. Phase: . Conditions: Congenital Heart Disease (CHD), Univentricular Heart

full page →ctgov ↗
›COMPLETEDphase readoutNCT07337603: Intraocular Pressure in Laparoscopic Inguinal Hernia Repair

Sponsor: Saglik Bilimleri Universitesi. Phase: . Conditions: Groin Hernia, Intraocular Pressure

full page →ctgov ↗
›RECRUITINGphase readoutNCT06767527: AK112 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally Advanced/ Metastatic Triple-negative Breast Cancer

Sponsor: Akeso. Phase: PHASE3. Conditions: Triple-Negative Breast Cancer (TNBC)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07307027: Stepwise Enteral Nutritional Algorithm and Patient Outcomes in Pediatric Intensive Care Units

Sponsor: Ain Shams University. Phase: NA. Conditions: Enteral Nutrition, Enteral Nutrition Feeding, Enteral Nutrition Intolerance in Critically Ill Patients

full page →ctgov ↗
›RECRUITINGphase readoutNCT07420127: Comparison of Two Different Doses of Phenylephrine on Oxytocin Hemodynamic Effect

Sponsor: Rawalpindi Medical College. Phase: PHASE4. Conditions: Phenylephrine, Cesarean Birth

full page →ctgov ↗
›COMPLETEDphase readoutNCT04023227: Efficacy and Safety of Sacubitril/Valsartan Compared With Enalapril on Morbidity, Mortality, and NT-proBNP Change in Patients With CCC

Sponsor: Novartis Pharmaceuticals. Phase: PHASE4. Conditions: Chagas Disease, Heart Failure

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07611227: Teleorthodontics Versus Conventional Follow-up During Early Interceptive Orthodontic Treatment in Children

Sponsor: Murad Alrashidi. Phase: NA. Conditions: Teledentistry, Orthodontics, Interceptive, Palatal Expansion Technique

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05731661: Optimize the Support of Patients in Pelvic Onco-gynecology Through Adapted Support Care in the Post-cancer Period. AFTERGYN Pilot Phase

Sponsor: Centre Francois Baclesse. Phase: NA. Conditions: Long Term Cancer Side Effects, Supportive Care in Cancer, Cancer Survivorship Care Plan, Advanced Nurse Practitioner, Pelvic Gynecological Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT02272361: Trial Comparing Laparoscopic Sacropexy and Vaginal Mesh Surgery for Women Cystocele Repair.

Sponsor: University Hospital, Lille. Phase: NA. Conditions: Cystocele

full page →ctgov ↗
›RECRUITINGphase readoutNCT06164561: 18F-FAPI PET/MRI Imaging in Myelofibrosis: a Prospective Observational Study.

Sponsor: First Affiliated Hospital of Zhejiang University. Phase: . Conditions: Myelofibrosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT07038486: Patient Engagement Investigation of NMS Assist

Sponsor: Newcastle University. Phase: NA. Conditions: Parkinson Disease

full page →ctgov ↗
›TERMINATEDphase readoutNCT05712278: A Study to Investigate Use of Off-the-shelf Natural Killer (NK) Cells (SAR445419) in Relapsed/Refractory Acute Myeloid Leukemia

Sponsor: Sanofi. Phase: PHASE1. Conditions: Acute Myeloid Leukaemia

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07569978: Efficacy and Safety of High-Concentration 35 kDa Hyaluronan Gel for Herpes Zoster-Associated Pain

Sponsor: Nakhia Impex LLC. Phase: NA. Conditions: Herpes Zoster, Zoster-Associated Pain, Postherpetic Neuralgia, Neuropathic Pain, Acute Pain

full page →ctgov ↗
›RECRUITINGphase readoutNCT07515885: Efficacy of Electroacupuncture for Acute Herpes Zoster-Associated Pain and Biomarker Evaluation

Sponsor: Dexiong Han. Phase: NA. Conditions: Acute Herpes Zoster

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07599943: Population Health Management -Increase Lung Cancer Screening in Community Health Centers (LungSMART)

Sponsor: University of Utah. Phase: NA. Conditions: Lung Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07360847: Profiling Patients With Rotator Cuff Related Shoulder Pain: What Factors Influence Outcomes With Non-operative Care in a Secondary Care Specialist Shoulder Clinic?

Sponsor: University of Limerick. Phase: . Conditions: Rotator Cuff Related Shoulder Pain, RCRSP

full page →ctgov ↗
›RECRUITINGphase readoutNCT07385508: Neurorehabilitation in Patients With Disorders of Consciousness: Multidimensional Ambispective Study on the Impact of Single and Combined Approaches

Sponsor: IRCCS Centro Neurolesi Bonino Pulejo. Phase: . Conditions: Disorder of Consciousness

full page →ctgov ↗
›COMPLETEDphase readoutNCT07060508: L9LS in Women of Childbearing Potential in Mali

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: PHASE2. Conditions: Malaria

full page →ctgov ↗
›COMPLETEDphase readoutNCT07428525: A Study to Evaluate AMG 133 in Participants With Varying Degrees of Hepatic Impairment or Normal Hepatic Function

Sponsor: Amgen. Phase: PHASE1. Conditions: Hepatic Impairment

full page →ctgov ↗
›RECRUITINGphase readoutNCT07151976: Thrombus Aspiration and Pathology and OCT Study

Sponsor: Fujita Health University. Phase: . Conditions: Acute Coronary Syndrome

full page →ctgov ↗
›RECRUITINGphase readoutNCT06765876: CART123 T Cells in Relapsed or Refractory CD123+ Hematologic Malignancies: A Dose Escalation Phase I Trial

Sponsor: Institute of Hematology and Blood Transfusion, Czech Republic. Phase: EARLY_PHASE1. Conditions: Leukemia, Myeloid, Acute(AML), Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic Syndromes (MDS), Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

full page →ctgov ↗
›COMPLETEDphase readoutNCT03313817: Pre and Post-arterial Recanalization Imaging of Central Retinal Artery Occlusions (CRAO)

Sponsor: Fondation Ophtalmologique Adolphe de Rothschild. Phase: . Conditions: Retinal Artery Occlusion, Magnetic Resonance Imaging, Diagnosis, Etiology, Prognosis

full page →ctgov ↗
›TERMINATEDphase readoutNCT05123040: Ruxolitinib, Human Chorionic Gonadotropin (uhCG/EGF), and Dose De-escalated Corticosteroids

Sponsor: Masonic Cancer Center, University of Minnesota. Phase: PHASE1. Conditions: Acute-graft-versus-host Disease

full page →ctgov ↗
← prev
page 103 of 149
next →